Copyright Reports & Markets. All rights reserved.

Global Growth/Differentiation Factor 8 Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Growth/Differentiation Factor 8 Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Growth/Differentiation Factor 8 Market Size Growth Rate by Product
      • 1.4.2 OSX-200
      • 1.4.3 SRK-015
      • 1.4.4 ACE-2494
      • 1.4.5 ACE-2798
      • 1.4.6 BMS-986089
      • 1.4.7 Others
    • 1.5 Market by End User
      • 1.5.1 Global Growth/Differentiation Factor 8 Market Size Growth Rate by End User
      • 1.5.2 Becker Muscular Dystrophy
      • 1.5.3 Fibrosis
      • 1.5.4 Myelofibrosis
      • 1.5.5 Sickle Cell Disease
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Growth/Differentiation Factor 8 Market Size
      • 2.1.1 Global Growth/Differentiation Factor 8 Revenue 2014-2025
      • 2.1.2 Global Growth/Differentiation Factor 8 Sales 2014-2025
    • 2.2 Growth/Differentiation Factor 8 Growth Rate by Regions
      • 2.2.1 Global Growth/Differentiation Factor 8 Sales by Regions
      • 2.2.2 Global Growth/Differentiation Factor 8 Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Growth/Differentiation Factor 8 Sales by Manufacturers
      • 3.1.1 Growth/Differentiation Factor 8 Sales by Manufacturers
      • 3.1.2 Growth/Differentiation Factor 8 Sales Market Share by Manufacturers
      • 3.1.3 Global Growth/Differentiation Factor 8 Market Concentration Ratio (CR5 and HHI)
    • 3.2 Growth/Differentiation Factor 8 Revenue by Manufacturers
      • 3.2.1 Growth/Differentiation Factor 8 Revenue by Manufacturers (2014-2019)
      • 3.2.2 Growth/Differentiation Factor 8 Revenue Share by Manufacturers (2014-2019)
    • 3.3 Growth/Differentiation Factor 8 Price by Manufacturers
    • 3.4 Growth/Differentiation Factor 8 Manufacturing Base Distribution, Product Types
      • 3.4.1 Growth/Differentiation Factor 8 Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Growth/Differentiation Factor 8 Product Type
      • 3.4.3 Date of International Manufacturers Enter into Growth/Differentiation Factor 8 Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Growth/Differentiation Factor 8 Sales by Product
    • 4.2 Global Growth/Differentiation Factor 8 Revenue by Product
    • 4.3 Growth/Differentiation Factor 8 Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Growth/Differentiation Factor 8 Breakdown Data by End User

    6 North America

    • 6.1 North America Growth/Differentiation Factor 8 by Countries
      • 6.1.1 North America Growth/Differentiation Factor 8 Sales by Countries
      • 6.1.2 North America Growth/Differentiation Factor 8 Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Growth/Differentiation Factor 8 by Product
    • 6.3 North America Growth/Differentiation Factor 8 by End User

    7 Europe

    • 7.1 Europe Growth/Differentiation Factor 8 by Countries
      • 7.1.1 Europe Growth/Differentiation Factor 8 Sales by Countries
      • 7.1.2 Europe Growth/Differentiation Factor 8 Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Growth/Differentiation Factor 8 by Product
    • 7.3 Europe Growth/Differentiation Factor 8 by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Growth/Differentiation Factor 8 by Countries
      • 8.1.1 Asia Pacific Growth/Differentiation Factor 8 Sales by Countries
      • 8.1.2 Asia Pacific Growth/Differentiation Factor 8 Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Growth/Differentiation Factor 8 by Product
    • 8.3 Asia Pacific Growth/Differentiation Factor 8 by End User

    9 Central & South America

    • 9.1 Central & South America Growth/Differentiation Factor 8 by Countries
      • 9.1.1 Central & South America Growth/Differentiation Factor 8 Sales by Countries
      • 9.1.2 Central & South America Growth/Differentiation Factor 8 Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Growth/Differentiation Factor 8 by Product
    • 9.3 Central & South America Growth/Differentiation Factor 8 by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Growth/Differentiation Factor 8 by Countries
      • 10.1.1 Middle East and Africa Growth/Differentiation Factor 8 Sales by Countries
      • 10.1.2 Middle East and Africa Growth/Differentiation Factor 8 Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Growth/Differentiation Factor 8 by Product
    • 10.3 Middle East and Africa Growth/Differentiation Factor 8 by End User

    11 Company Profiles

    • 11.1 Acceleron Pharma, Inc.
      • 11.1.1 Acceleron Pharma, Inc. Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Acceleron Pharma, Inc. Growth/Differentiation Factor 8 Products Offered
      • 11.1.5 Acceleron Pharma, Inc. Recent Development
    • 11.2 Atara Biotherapeutics, Inc.
      • 11.2.1 Atara Biotherapeutics, Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Atara Biotherapeutics, Inc. Growth/Differentiation Factor 8 Products Offered
      • 11.2.5 Atara Biotherapeutics, Inc. Recent Development
    • 11.3 Bristol-Myers Squibb Company
      • 11.3.1 Bristol-Myers Squibb Company Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Bristol-Myers Squibb Company Growth/Differentiation Factor 8 Products Offered
      • 11.3.5 Bristol-Myers Squibb Company Recent Development
    • 11.4 Eli Lilly and Company
      • 11.4.1 Eli Lilly and Company Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Eli Lilly and Company Growth/Differentiation Factor 8 Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Eli Lilly and Company Growth/Differentiation Factor 8 Products Offered
      • 11.4.5 Eli Lilly and Company Recent Development
    • 11.5 Milo Biotechnology LLC
      • 11.5.1 Milo Biotechnology LLC Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Milo Biotechnology LLC Growth/Differentiation Factor 8 Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Milo Biotechnology LLC Growth/Differentiation Factor 8 Products Offered
      • 11.5.5 Milo Biotechnology LLC Recent Development
    • 11.6 Pfizer Inc.
      • 11.6.1 Pfizer Inc. Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Pfizer Inc. Growth/Differentiation Factor 8 Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Pfizer Inc. Growth/Differentiation Factor 8 Products Offered
      • 11.6.5 Pfizer Inc. Recent Development
    • 11.7 Regeneron Pharmaceuticals, Inc.
      • 11.7.1 Regeneron Pharmaceuticals, Inc. Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Regeneron Pharmaceuticals, Inc. Growth/Differentiation Factor 8 Products Offered
      • 11.7.5 Regeneron Pharmaceuticals, Inc. Recent Development
    • 11.8 Sarepta Therapeutics, Inc.
      • 11.8.1 Sarepta Therapeutics, Inc. Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Sarepta Therapeutics, Inc. Growth/Differentiation Factor 8 Products Offered
      • 11.8.5 Sarepta Therapeutics, Inc. Recent Development
    • 11.9 Scholar Rock, Inc.
      • 11.9.1 Scholar Rock, Inc. Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Scholar Rock, Inc. Growth/Differentiation Factor 8 Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Scholar Rock, Inc. Growth/Differentiation Factor 8 Products Offered
      • 11.9.5 Scholar Rock, Inc. Recent Development

    12 Future Forecast

    • 12.1 Growth/Differentiation Factor 8 Market Forecast by Regions
      • 12.1.1 Global Growth/Differentiation Factor 8 Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Growth/Differentiation Factor 8 Revenue Forecast by Regions 2019-2025
    • 12.2 Growth/Differentiation Factor 8 Market Forecast by Product
      • 12.2.1 Global Growth/Differentiation Factor 8 Sales Forecast by Product 2019-2025
      • 12.2.2 Global Growth/Differentiation Factor 8 Revenue Forecast by Product 2019-2025
    • 12.3 Growth/Differentiation Factor 8 Market Forecast by End User
    • 12.4 North America Growth/Differentiation Factor 8 Forecast
    • 12.5 Europe Growth/Differentiation Factor 8 Forecast
    • 12.6 Asia Pacific Growth/Differentiation Factor 8 Forecast
    • 12.7 Central & South America Growth/Differentiation Factor 8 Forecast
    • 12.8 Middle East and Africa Growth/Differentiation Factor 8 Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Growth/Differentiation Factor 8 Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Growth/Differentiation Factor 8 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Growth/Differentiation Factor 8 market based on company, product type, end user and key regions.

      This report studies the global market size of Growth/Differentiation Factor 8 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Growth/Differentiation Factor 8 in these regions.
      This research report categorizes the global Growth/Differentiation Factor 8 market by top players/brands, region, type and end user. This report also studies the global Growth/Differentiation Factor 8 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Acceleron Pharma, Inc.
      Atara Biotherapeutics, Inc.
      Bristol-Myers Squibb Company
      Eli Lilly and Company
      Milo Biotechnology LLC
      Pfizer Inc.
      Regeneron Pharmaceuticals, Inc.
      Sarepta Therapeutics, Inc.
      Scholar Rock, Inc.

      Market size by Product
      OSX-200
      SRK-015
      ACE-2494
      ACE-2798
      BMS-986089
      Others
      Market size by End User
      Becker Muscular Dystrophy
      Fibrosis
      Myelofibrosis
      Sickle Cell Disease
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Growth/Differentiation Factor 8 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Growth/Differentiation Factor 8 market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Growth/Differentiation Factor 8 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Growth/Differentiation Factor 8 submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Growth/Differentiation Factor 8 are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Growth/Differentiation Factor 8 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now